"Neoplasm Grading" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.
| Descriptor ID |
D060787
|
| MeSH Number(s) |
E01.789.612
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Grading".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Grading".
This graph shows the total number of publications written about "Neoplasm Grading" by people in this website by year, and whether "Neoplasm Grading" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 7 | 7 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 2 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 3 | 3 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Grading" by people in Profiles.
-
Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm. Ann Hematol. 2021 Jan; 100(1):97-104.
-
Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients. Breast Cancer Res Treat. 2020 Jan; 179(2):403-414.
-
Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women. BMC Cancer. 2019 Aug 08; 19(1):787.
-
Prevalence of circulating tumor cells in early breast cancer patients 2 and 5?years after adjuvant treatment. Breast Cancer Res Treat. 2018 Oct; 171(3):571-580.
-
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial. Leukemia. 2018 07; 32(7):1657-1669.
-
Filtration based assessment of CTCs and CellSearch? based assessment are both powerful predictors of prognosis for metastatic breast cancer patients. BMC Cancer. 2018 02 20; 18(1):204.
-
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry. Breast. 2018 Feb; 37:42-51.
-
Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study. Ann Surg Oncol. 2017 May; 24(5):1314-1321.
-
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer. Clin Cancer Res. 2016 05 15; 22(10):2583-93.
-
May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer? Gynecol Endocrinol. 2016; 32(1):58-60.
MeSH information
